Malignant Appendix Neoplasm — Trials

Malignant Appendix Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

72 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 28
Recruiting: 19
Ph III recruiting: 1
Growth YoY: —
Industry share: 7%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03287947	LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma	terminated	Phase 2	5	Wake Forest University Health SciencesOTHER	1	Aug 9, 2022	clinicaltrials
NCT00903396	Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer	terminated	Phase 2	7	Alliance for Clinical Trials in OncologyOTHER	1	Nov 24, 2017	clinicaltrials